Richard P. Lifton - Genetic Mutations

Author Information

Richard P. Lifton is a prominent geneticist affiliated with the Laboratory of Human Genetics and Genomics at The Rockefeller University, New York, NY 10065. His research spans multiple areas of genetics, with a focus on gene discovery and the genetic underpinnings of various diseases.

Research Contributions

Richard P. Lifton has made significant contributions to the field of genetics, particularly in understanding the genetic basis of diseases. His research includes the discovery of gene variants associated with conditions such as nonsyndromic craniosynostosis, hypoalphalipoproteinemia, spina bifida, congenital heart disease, and hydrocephalus. He has also explored the genetic factors influencing the severity of COVID-19, and his work has implications for prenatal neurogenesis and congenital disorders. Lifton's efforts in facilitating gene discovery through initiatives like the Centers for Mendelian Genomics have been instrumental in advancing the field.

Aliases

Richard P. Lifton is also known by several aliases, including R. P. Lifton, Rick P. Lifton, R. Lifton, Richard Lifton, and R. P. Lifton.

Publication and Citation Metrics

Metric	Value
Citation Count	81,303
H-Index	140
Paper Count	569

Publications:

Genetic Influence on Neurodevelopment in Nonsyndromic Craniosynostosis

DOI: 10.1097/PRS.0000000000008976

Year: 2022

Centers for Mendelian Genomics: A decade of facilitating gene discovery.

DOI: 10.1016/j.gim.2021.12.005

Year: 2022

Whole Exome Sequencing Reveals Damaging Gene Variants Associated with Hypoalphalipoproteinemia.

DOI: 10.1016/j.jlr.2022.100209

Year: 2022

Whole exome sequencing identifies potential candidate genes for spina bifida derived from mouse models

DOI: 10.1002/ajmg.a.62644

Year: 2022

Genome-Wide De Novo Variants in Congenital Heart Disease Are Not Associated With Maternal Diabetes or Obesity

DOI: 10.1161/CIRCGEN.121.003500

Year: 2022

The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

DOI: 10.21203/rs.3.rs-1225906/v1

Year: 2022

Impaired neurogenesis alters brain biomechanics in a neuroprogenitor-based genetic subtype of congenital hydrocephalus.

DOI: 10.1038/s41593-022-01043-3

Year: 2022

Quantifying concordant genetic effects of de novo mutations on multiple disorders

DOI: 10.1101/2021.06.13.448234

Year: 2021

Generation of Monogenic Candidate Genes for Human Nephrotic Syndrome Using 3 Independent Approaches

DOI: 10.1016/j.ekir.2020.11.013

Year: 2021

Integrative Genomics Implicates Genetic Disruption of Prenatal Neurogenesis in Congenital Hydrocephalus

DOI: 10.1093/NEUROS/NYAA447_572

Year: 2021

Can Synonymous Codons Contribute to Disease?

How is Research Evolving in This Field?

How does Research Advance Treatment?

What Are the Benefits of Pharmacogenomics?

What are the Symptoms and Complications?

What Are the Limitations of CGH?

What Role Does Personalized Medicine Play?

How Does CRISPR Work?

Why is Sanger Sequencing Important in Studying Genetic Mutations?

How Do Insertion Mutations Occur?

Partnered Content Networks

Relevant Topics